Company: GNMSF
Filing Date: 2025-02-12
Form Type: S-8
Source: 0000947871-25-000131
Chunk: 2

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: S-8
Chunk 2
---
 modified or superseded, to constitute a part of this Registration Statement.

| Item 4. | Description of Securities. |

Not applicable

| Item 5. | Interests of Named Experts and Counsel. |

Not applicable

| Item 6. | Indemnification of Directors and Officers. |

According to the Danish Companies Act, shareholders,
at the general meeting, are permitted to discharge the Registrant’s board members and registered managers from liability for any
particular financial year based on a resolution relating to the period covered by the financial statements for the previous financial
year. This discharge means that the shareholders will relieve such board members and registered managers from liability to the Registrant.
However, shareholders cannot discharge any claims by individual shareholders or other third parties. The discharge can be set aside in
case the general meeting prior to its decision to discharge was not presented with all reasonable information necessary for the general
meeting to assess the matter at hand. In addition, the Registrant provides its board members and registered managers with directors’
and officers’ liability insurance.

| Item 7. | Exemption from Registration Claimed. |

Not applicable.

| Item 8. | Exhibits. |

The following exhibits are filed as part of this Registration
Statement:

| Exhibit Number | Description of Document                                                                                                                                                                                                                   |
| 4.1            | English translation of the Articles of Association of Genmab A/S, as in effect on the date hereof, filed as Exhibit 3.1 to the Registrant’s Current Report on Form 6-K filed with the Commission on December 4, 2024 (File No. 001-38976) |
| 4.2            | Genmab A/S 2021 Restricted Stock Units Program (incorporated by reference to Exhibit 4.2 to the Registrant’s Registration Statement on Form S-8, filed with the Commission on February 25, 2021 (File No. 333-253519))                    |
| 5.1*           | Opinion of Kromann Reumert, with respect to the legality of the securities being registered                                                                                                                                               |
| 23.1*          | Consent of Kromann Reumert (included in the opinion filed as Exhibit 5.1)                                                                                                                                                                 |
| 23.2*          | Consent of Deloitte Statsautoriseret Revisionspartnerselskab                                                                                                                                                                              |
| 24.1*          | Limited Power of Attorney of the directors of the Registr